GlassScriptPhysician profile
Ronnie A Mohammed
NPI 1669463774
$753.12
in general payments reported to CMS, 2019-2025
18 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.00 · 2020: $19.15 · 2021: $312 · 2022: $109 · 2023: $32.75 · 2024: $69.03 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $225 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $225.24 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $84.21 | 2021-2022 | |
| Mannkind Corporation | $81.66 | 2021-2025 | |
| Medtronic, INC. | $73.37 | 2021-2025 | Minimed 780g, Intellis Adaptivestim |
| Beta Bionics, INC. | $58.92 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Lilly USA, LLC | $54.33 | 2021 | |
| Xeris Pharmaceuticals, INC. | $49.52 | 2021-2024 | Recorlev |
| Dexcom, INC. | $39.34 | 2021 | |
| Novo Nordisk INC | $39.31 | 2019-2025 | Rybelsus, Ozempic |
| Zealand Pharma US, INC. | $38.54 | 2021-2022 | |
| Amgen INC. | $36.59 | 2025 | Evenity, Repatha |
| Becton, Dickinson and Company | $35.04 | 2021 | |
| Sanofi-Aventis U.S. LLC | $32.52 | 2021-2023 | |
| Ascensia Diabetes Care US INC. | $29.87 | 2021 | |
| Tandem Diabetes Care, INC. | $27.43 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Valeritas, INC. | $21.18 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.15 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $16.98 | 2021 | |
| Insulet Corporation | $15.16 | 2023 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronnie Mohammed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.